VolitionRx Ltd. (NYSE AMERICAN: VNRX) is a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help diagnose a range of cancers and other diseases. Early diagnosis has the potential to not only prolong the life of patients, but also to improve their quality of life. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid – an indication that disease is present. Volition is primarily focused on human diagnostics but also has a subsidiary focused on animal diagnostics.
For more information, visit company’s website: www.volitionrx.com
Scott Powell
Executive Vice President & Head of Investor Relations, VolitionRx Limited
Chief Financial Officer, Volition America, Inc.
Scott has more than 20 years of experience in the U.S. capital markets, investment banking, investor relations and corporate communication. Based in New York City, he directs a comprehensive capital markets program and investor relations strategy for Volition. His role includes strategic interactions with institutional investors, analysts, investment banks, and the financial media. Scott has served as Head of Investor Relations for four public companies, including Volition, and worked for several years as an investment banker in New York City. He earned his Bachelor of Science in Business Administration from Bryant University in Smithfield, RI, his Master of Arts and Doctor of Philosophy degrees from Brown University in Providence, RI, and his Certificate in Business from Columbia University in New York City.
GCFF Virtual Conference – Investing in Innovation
September 10th, 2020 Thursday
8:30am – 1:30pm PST (11:30am – 4:30 EST)
Covering the healthcare, technology, fintech and cannabis sectors the GCFF Virtual Conference – Investing in Innovation will provide its participants with access to exciting investment opportunities that are at the cusp of value growth. The bilingual online event will feature 12 public and private company presentations and will broadcasted in both English and Mandarin Chinese channels. Register for our virtual event today!
